LOGIN
Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19
May 2021
Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia
Eur J Clin Invest. 2020 Oct 31 : e13435.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Twenty-two patients hospitalized with severe COVID-19 were randomized to receive oxygen therapy using a high-flow nasal cannula oxygen system (n=22) or conventional oxygen therapy (n=10). Outcomes of interest included vitals (i.e., heart rate; respiratory rate; PaO2/FiO2 oxygenation index), infection indexes (C-reactive protein [CRP]; procalcitonin [PCT]; white blood cell count; lymphocyte count),...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.